Exhibit
10.1
WARRANT PURCHASE AGREEMENT
Dated as of July 23,
2008
by and between
ELECTRO ENERGY, INC.
and
THE QUERCUS TRUST
TABLE OF CONTENTS
|
|
|
|
Page
|
|
|
|
|
|
|
WARRANT
PURCHASE AGREEMENT
|
1
|
|
|
|
|
|
|
ARTICLE I
PURCHASE AND SALE OF WARRANT
|
1
|
|
|
1.1.
|
Purchase and
Sale of Warrant
|
1
|
|
|
1.2.
|
Underlying
Shares
|
2
|
|
|
|
|
|
|
ARTICLE II
REPRESENTATIONS AND WARRANTIES
|
2
|
|
|
2.1.
|
Representations
and Warranties of the Company
|
2
|
|
|
2.2.
|
Representations
and Warranties of the Purchaser
|
3
|
|
|
|
|
|
|
ARTICLE III
COVENANTS
|
3
|
|
|
3.1.
|
Securities
Compliance
|
3
|
|
|
3.2.
|
Registration
and Listing
|
3
|
|
|
3.3.
|
Inspection
Rights
|
3
|
|
|
3.4.
|
Compliance with
Laws
|
4
|
|
|
3.5.
|
Keeping of
Records and Books of Account
|
4
|
|
|
3.6.
|
Reporting
Requirements
|
4
|
|
|
3.7.
|
Other
Agreements
|
4
|
|
|
3.8.
|
Use of
Proceeds
|
4
|
|
|
3.9.
|
Reporting
Status
|
4
|
|
|
3.10.
|
Disclosure of
Transaction
|
5
|
|
|
3.11.
|
Amendments
|
5
|
|
|
3.12.
|
Reservation of
Shares
|
5
|
|
|
3.13.
|
Transfer Agent
Instructions
|
5
|
|
|
3.14.
|
Form S-3
Eligibility
|
5
|
|
|
3.15.
|
Right of First
Refusal
|
5
|
|
|
3.16.
|
Consultant
|
6
|
|
|
3.17.
|
Prohibition
from Exercise, Shareholder Approval
|
7
|
|
|
|
|
|
|
ARTICLE IV
CONDITIONS
|
7
|
|
|
4.1.
|
Conditions
Precedent to the Obligation of the Company
|
7
|
|
|
4.2.
|
Conditions
Precedent to the Obligation of the Purchaser
|
8
|
|
|
|
|
|
|
ARTICLE V
CERTIFICATE LEGEND
|
10
|
|
|
5.1.
|
Legend
|
10
|
|
|
|
|
|
|
ARTICLE VI
INDEMNIFICATION
|
11
|
|
|
6.1.
|
Company
Indemnity
|
11
|
|
|
6.2.
|
Indemnification
Procedure
|
11
|
|
|
|
|
|
|
ARTICLE VII
MISCELLANEOUS
|
12
|
|
|
7.1.
|
Short
Sales
|
12
|
|
|
7.2.
|
Fees and
Expenses
|
12
|
|
|
7.3.
|
Specific
Performance; Consent to Jurisdiction; Venue
|
13
|
TABLE OF CONTENTS
(continued)
|
|
|
|
Page
|
|
|
|
|
|
|
|
7.4.
|
Entire
Agreement; Amendment
|
13
|
|
|
7.5.
|
Notices
|
13
|
|
|
7.6.
|
Waivers
|
14
|
|
|
7.7.
|
Headings
|
14
|
|
|
7.8.
|
Successors and
Assigns
|
14
|
|
|
7.9.
|
No Third Party
Beneficiaries
|
15
|
|
|
7.10.
|
Governing
Law
|
15
|
|
|
7.11.
|
Survival
|
15
|
|
|
7.12.
|
Counterparts
|
15
|
|
|
7.13.
|
Publicity
|
15
|
|
|
7.14.
|
Severability
|
15
|
|
|
7.15.
|
Further
Assurances
|
15
|
WARRANT PURCHASE
AGREEMENT
This
WARRANT PURCHASE AGREEMENT, dated as of July 23, 2008 (this “
Agreement ”), by and between Electro Energy, Inc., a
Florida corporation (the “ Company ”), and The
Quercus Trust, a ______ trust (the “Purchaser
”).
W I T N E S S E T H:
WHEREAS,
the parties hereto entered into that certain Debenture and Warrant
Purchase Agreement, dated as of December 7, 2007 (the “2007
Purchase Agreement”), and capitalized terms contained herein,
to the extent they are not defined herein, shall have the meanings
as may be expressly provided in the 2007 Purchase
Agreement.
WHEREAS,
subject to the terms and conditions set forth in this Agreement and
pursuant to Section 4(2) of the Securities Act of 1933, as amended,
and the rules and regulations promulgated thereunder (the “
Securities Act ”), the Company desires to issue and
sell to the Purchaser, and the Purchaser desires to purchase from
the Company, securities of the Company as more fully described in
this Agreement.
NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in
this Agreement, and for other good and valuable consideration, the
receipt and adequacy of which are hereby acknowledged, the parties
hereto agree as follows:
ARTICLE I
PURCHASE AND SALE OF WARRANT
1.1.
Purchase and Sale of Warrant .
(a)
Upon the terms and conditions contained herein, the Company shall
issue to Purchaser a Warrant to Purchase Common Stock, in
substantially the form attached hereto as Exhibit A (the
“ Warrant ”), to purchase up to One Million
Eight Hundred Seventy-Five Thousand (1,875,000) shares of the
Company’s common stock, par value $0.001 per share (the
“ Common Stock ”). The Warrant shall expire
three (3) years following the Closing Date and shall have an
exercise price per share equal to the Warrant Price (as defined in
the Warrant).
(b)
Upon the terms and conditions contained herein, by written notice
given on or before August 31, 2008, the Purchaser shall have the
option to purchase an additional warrant for the purchase of up to
Six Hundred Twenty-Five Thousand (625,000) shares of Common Stock,
in substantially the same form as the Warrant (the
“Additional Warrant”).
(c)
Purchase Price. Subject to the terms and conditions
hereof, the Company agrees to issue and sell to the Purchaser and,
in consideration of and in express reliance upon the
representations, warranties, covenants, terms and conditions of
this Agreement, the Purchaser agrees to purchase the Warrant for a
purchase price of Seven Hundred Fifty Thousand Dollars ($750,000)
(the “Purchase Price ”), in cash. In the event
that the Purchaser exercises its option to purchase the Additional
Warrant as provided in Section 1.1(b) herein, the Purchaser agrees
to purchase such Additional Warrant for a purchase price of Two
Hundred Fifty Thousand Dollars ($250,000) in cash.
1
(d)
Closing. The closing of the purchase and sale of the
Warrant to be acquired by the Purchaser from the Company under this
Agreement shall take place at the offices of Lev & Berlin,
P.C., 200 Connecticut Avenue, 5th Floor, Norwalk, Connecticut 06854
(the “ Closing ”) at 10:00 a.m., Eastern time,
(i) on July 23, 2008; provided, that all of the conditions set
forth in Article IV hereof and applicable to the Closing shall have
been fulfilled or waived in accordance herewith, or (ii) at such
other time and place or on such date as the Purchaser and the
Company may agree upon (the “ Closing Date ”).
Subject to the terms and conditions of this Agreement, at the
Closing the Company shall deliver or cause to be delivered to the
Purchaser the Warrant and any other documents required to be
delivered pursuant to Article IV hereof. At the Closing, the
Purchaser shall deliver the Purchase Price by wire transfer to a
bank account designated by the Company. The closing of the purchase
and sale of the Additional Warrant shall take place at the offices
of Lev & Berlin, P.C., within ten (10) days of the
Company’s receipt of the Purchaser’s notice of exercise
of its option to purchase the Additional Warrant, at which closing
(i) the Company shall deliver to Purchaser (A) the Additonal
Warrant and (B) a written certificate verifying the truth, accuracy
and completeness of the the representations and warranties set
forth in Section 2.1 hereinbelow as of the date of such closing and
(ii) the Purchaser will deliver to the Company the purchase price
for the Additional Warrant by wire transfer to a bank account
designated by the Company.
(e)
Underlying Shares. The Company has authorized and has
reserved and covenants to continue to reserve, free of preemptive
rights and other similar contractual rights of stockholders, a
sufficient number of its authorized but unissued shares of Common
Stock to effect the exercise the Warrant and the Additional Warrant
Any shares of Common Stock issuable upon exercise of the Warrant
and the Additional Warrant (and such shares when issued) are herein
referred to as the “Underlying Shares.” The Warrant,
the Additional Warrant and the Underlying Shares are sometimes
collectively referred to herein as the
“Securities.”
ARTICLE II
REPRESENTATIONS AND
WARRANTIES
2.1.
Representations and Warranties of the Company .
The Company hereby represents and warrants to the Purchaser, as of
the date hereof and the Closing Date (except as set forth below;
and as may be modified by or updated by the Commission Documents)
that the Company’s representations and warranties set forth
in Section 2.1 of the 2007 Purchase Agreement are hereby repeated
and incorporated herein by reference with the following
modifications and additions:
(a)
Capitalization . The authorized capital stock of
the Company as of the date hereof is set forth on Schedule
2.1(a) hereto, subject only to a 1 for 5 reverse split effected
on July 9, 2008.
2
(b)
Commission Documents; Financial Statements . At
the times of their respective filings, the Forms 10-QSB (or Form
10-Q, as the case may be) for the three most recent fiscal quarters
(collectively, the “ Forms 10-QSB ”) and the
Form 10-KSB for the fiscal year ended December 31, 2007 (the
“ Form 10-KSB ”) complied in all material
respects with the requirements of the Exchange Act and the rules
and regulations of the Commission promulgated thereunder, and the
Forms 10-QSB and Form 10-KSB did not contain any untrue statement
of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made,
not misleading.
2.2.
Representations and Warranties of the Purchaser
. The Purchaser hereby represents and warrants to the
Company as follows as of the date hereof and as of the Closing Date
that the Purchaser’s representations and warranties that are
set forth in Sections 2.2 of the 2007 Purchase Agreement are hereby
repeated and incorporated herein by reference.
ARTICLE III
COVENANTS
The
Company covenants with the Purchaser as follows, which covenants
are for the benefit of the Purchaser and its permitted
assignees.
3.1.
Securities Compliance . The Company shall notify
the Commission in accordance with its rules and regulations, of the
transactions contemplated herein and by any of the documents
executed in connection herewith, including the Warrant and the
Registration Rights Agreement, dated as of the date hereof (the
“Transaction Documents”), and shall take all other
necessary action and proceedings as may be required and permitted
by applicable law, rule and regulation, for the legal and valid
issuance of the Securities to the Purchaser, or its subsequent
holders.
3.2.
Registration and Listing . The Company shall
cause its Common Stock to continue to be registered under Sections
12(g) of the Exchange Act, to comply in all respects with its
reporting and filing obligations under the Exchange Act, to comply
with all requirements related to any registration statement filed
pursuant to this Agreement, and to not take any action or file any
document (whether or not permitted by the Securities Act or the
rules promulgated thereunder) to terminate or suspend such
registration or to terminate or suspend its reporting and filing
obligations under the Exchange Act or Securities Act, except as
permitted herein. The Company will take all action necessary to
continue the listing or trading of its Common Stock on the Nasdaq
Capital Market or other exchange or market on which the Common
Stock is trading. Subject to the terms of the Transaction
Documents, the Company further covenants that it will take such
further action as the Purchaser may reasonably request, all to the
extent required from time to time to enable the Purchaser to sell
the Securities without registration under the Securities Act within
the limitation of the exemptions provided by Rule 144 promulgated
under the Securities Act. Upon the request of the Purchaser, the
Company shall deliver to the Purchaser a written certification of a
duly authorized officer as to whether it has complied with the
issuer requirements of Rule 144.
3
3.3.
Inspection Rights . Provided the same would not
be in violation of Regulation FD, the Company shall permit, during
normal business hours and upon reasonable request and reasonable
advance notice, the Purchaser or any employees, agents or
representatives thereof, so long as the Purchaser shall hold the
Debenture or shall beneficially own any Underlying Shares, for
purposes reasonably related to the Purchaser’s interests as a
stockholder, to examine the publicly available, non-confidential
records and books of account of, and visit and inspect the
properties, assets, operations and business of the Company and any
Subsidiary, and to discuss the publicly available, non-confidential
affairs, finances and accounts of the Company and any Subsidiary
with any of its officers, consultants, directors and key
employees.
3.4.
Compliance with Laws . The Company shall comply,
and cause each Subsidiary to comply, with all applicable laws,
rules, regulations and orders, noncompliance with which would be
reasonably likely to have a Material Adverse Effect.
3.5.
Keeping of Records and Books of Account . The
Company shall keep and cause each Subsidiary to keep adequate
records and books of account, in which complete entries will be
made in accordance with GAAP consistently applied, reflecting all
financial transactions of the Company and its Subsidiaries, and in
which, for each fiscal year, all proper reserves for depreciation,
depletion, obsolescence, amortization, taxes, bad debts and other
purposes in connection with its business shall be made.
3.6.
Reporting Requirements . If the Commission
ceases making the Company’s periodic reports available via
the Internet without charge, then the Company shall furnish the
following to the Purchaser so long as the Purchaser shall
beneficially own Securities:
(a)
Quarterly Reports filed with the Commission on Form 10-Q as soon as
practical after the document is filed with the Commission, and in
any event within five (5) days after the document is filed with the
Commission;
(b)
Annual Reports filed with the Commission on Form 10-K as soon as
practical after the document is filed with the Commission, and in
any event within five (5) days after the document is filed with the
Commission; and
(c)
Copies of all notices, information and proxy statements in
connection with any meetings that are, in each case, provided to
holders of shares of Common Stock, contemporaneously with the
delivery of such notices or information to such holders of Common
Stock.
3.7.
Other Agreements . The Company shall not enter
into any agreement in which the terms of such agreement would
restrict or impair the right or ability to perform of the Company
or any Subsidiary under any Transaction Document.
3.8.
Use of Proceeds . The net proceeds from the sale
of the Securities hereunder shall be used by the Company for
working capital and general corporate purposes, including growth
initiatives.
3.9.
Reporting Status . So long as the Purchaser
beneficially owns any of the Securities, the Company shall timely
file all reports required to be filed with the Commission pursuant
to the Exchange Act, and the Company shall not terminate its status
as an issuer required to file reports under the Exchange Act even
if the Exchange Act or the rules and regulations thereunder would
permit such termination.
4
3.10.
Disclosure of Transaction . The Company shall
issue a press release describing the material terms of the
transactions contemplated hereby (the “ Press Release
”) not later than the second Trading Day following the
Closing Date. The Company shall also file with the Commission a
Current Report on Form 8-K (the “ Form 8-K ”)
describing the material terms of the transactions contemplated
hereby (and attaching as exhibits thereto this Agreement, the form
of Warrant and the Press Release) as soon as practicable following
the Closing Date but in no event more than four (4) Trading Days
following the Closing Date, which Press Release and Form 8-K shall
be subject to prior review and reasonable comment by the Purchaser.
“ Trading Day ” means any day during which the
principal exchange on which the Common Stock is traded shall be
open for trading.
3.11.
Amendments . The Company shall not amend or
waive any provision of the Articles or By-laws of the Company in
any way that would adversely affect exercise rights, voting rights,
or redemption rights of the holder of the Securities.
3.12.
Reservation of Shares . Subject to Section 1.3
hereof, so long as the Warrant or the Additional Warrant remain
outstanding, the Company shall take all action necessary to at all
times have authorized and reserved for the purpose of issuance of a
sufficient number of shares of Common Stock needed to provide for
the issuance of the Underlying Shares.
3.13.
Transfer Agent Instructions . The Company shall
issue irrevocable instructions to its transfer agent, and any
subsequent transfer agent, to issue certificates, registered in the
name of the Purchaser, for the Underlying Shares in such amounts as
specified from time to time by the Purchaser to the Company upon
exercise of the Warrant in the form of Exhibit D attached to
the 2007 Purchase Agreement (the “ Irrevocable Transfer
Agent Instructions ”). Prior to registration of the
Underlying Shares under the Securities Act, all such certificates
shall bear the restrictive legend specified in Section 5.1 of this
Agreement. The Company warrants that no instruction other than the
Irrevocable Transfer Agent Instructions referred to in this Section
3.13 will be given by the Company to its transfer agent and that
the Underlying Shares shall otherwise be freely transferable on the
books and records of the Company as and to the extent provided in
this Agreement. If the Purchaser provides the Company with an
opinion of counsel, in a generally acceptable form, to the effect
that a public sale, assignment or transfer of the Underlying Shares
may be made without registration under the Securities Act or the
Purchaser provides the Company with reasonable assurances that the
Underlying Shares can be sold pursuant to Rule 144 without any
restriction as to the number of securities acquired as of a
particular date that can then be immediately sold, the Company
shall permit the transfer, and, in the case of the Underlying
Shares, promptly instruct its transfer agent to issue one or more
certificates in such name and in such denominations as specified by
the Purchaser and without any restrictive legend.
3.14.
Form S-3 Eligibility . The Company currently
meets the “registrant eligibility” and transaction
requirements set forth in the general instructions to Form S-3
applicable to “resale” registrations on Form S-3
and the Company shall file all reports required to be filed by the
Company with the Commission in a timely manner.
5
3.15
Right of First Refusal .
(a)
For the twelve (12) month period following the Closing, the
Purchaser will have the right of first refusal (the “Initial
Purchase Right ”) to purchase, on the same terms as
other investors, up to one hundred percent (100%) of any debt
securities, equity securities, securities convertible into equity
securities, or options or warrants therefor (“ Purchase
Securities ”) that the Company proposes to offer, other
than the securities excluded by paragraph (e) below.
(b)
Subsequent to the twelve (12) month period following the Closing,
the Purchaser will have the right of first refusal (the
“Pro-Rata Purchase Right ”) to purchase, on the
same terms as other investors, that percentage of any Purchase
Securities that the Company proposes to offer, other than the
securities excluded by paragraph (e) below, which is equal to the
Purchaser’s pro rata ownership of the Common Stock of the
Company on a fully diluted basis. The Initial Purchase Right and
the Pro-Rata Purchase Right are collectively referred to herein as
the “Purchase Rights”.
(c)
If the Company proposes to issue any Purchase Securities, it shall
give the Purchaser written notice of its intention, describing the
Purchase Securities, the price and the terms and conditions upon
which the Company proposes to issue the same, together with a
signed and accepted term sheet. The Purchaser shall have ten (10)
Trading Days from the giving of such notice to elect to purchase
all or part (in the case of the Initial Purchase Right), or part
(in the case of the Pro-Rata Purchase Right), of the Purchase
Securities for the price and upon the terms and conditions
specified in the notice by giving written notice to the Company and
stating therein the quantity of such Purchase Securities to be
purchased.
(d)
The Purchaser shall then effect the purchase of the Purchase
Securities at the closing of the issuance of Purchase Securities
described in the notice delivered by the Company pursuant to
paragraph (c) above. On the date of such closing, the Company shall
deliver to the Purchaser the certificates representing the Purchase
Securities to be purchased by the Purchaser, each certificate to be
properly endorsed for transfer, and at such time, the Purchaser
shall pay the purchase price for the Purchase
Securities.
(e)
If the Purchaser fails to exercise in full its Purchase Right, the
Company shall have ninety (90) days thereafter to sell the Purchase
Securities in respect of which the Purchaser’s rights were
not exercised, at a price and upon general terms and conditions no
more favorable to the purchaser thereof than specified in the
Company’s notice to the Purchaser pursuant to paragraph (c)
above. If the Company has not sold such Purchase Securities within
such ninety (90) days, the Company shall not thereafter issue or
sell any Purchase Securities, without first again complying with
this Section 3.15.
(b)
The Purchase Right established by this Section 3.15 shall have no
application to any of the following issuances of Purchase
Securities (collectively, the “ Excluded Securities
”):
6
|
|
|
(i)
shares of Common Stock issued or issuable to employees, directors
or consultants pursuant to equity holder plans maintained by the
Company and registered with the Commission on Form S-8;
|
|
|
|
(ii)
shares of Common Stock issued or issuable upon the exercise or
conversion of currently outstanding options, warrants or
convertible securities; or
|
|
|
|
(iii)
shares of Common Stock issued or issuable on the conversion of the
Debenture or exercise of the Warrant issued to the Purchaser
concurrently with the Debenture; or
|
|
|
|
(iv)
shares of Common Stock issued or issuable solely as consideration
for bank financings, equipment leases, investor relations/public
relations services, business acquisitions, mergers, strategic
partnerships, or public offerings.
|
3.16
Consultant. The Company shall engage the
services of Mr. Lyle Deitsch (the “Consultant”) as a
consultant to work with Company management in connection with
overseeing (i) the progress of certain Company performance
milestones, (ii) the design and implementation of the
Company’s marketing plan and (iii) management review (the
“Consultancy”). The term of the Consultancy shall
commence on July 23 , 2008 and end on September 1, 2008.
Notwithstanding the foregoing, if the Purchaser shall exercise its
option to Purchase the Additional Warrant set forth in Section
1.1(b) hereof, the term of the Consultancy shall expire on December
31, 2008. The Consultancy shall include the Consultant’s
presence at the Company’s facilities in Gainesville, Florida
for at least three (3) days per week and the Company shall pay the
Consultant a fee of Ten Thousand Dollars ($10,000) per month plus
reasonable travel expenses.
3.17
Prohibition from Exercise, Shareholder Approval
. Until the Company has obtained the approval of the
transaction and issuance(s) of securities contemplated herein by a
majority of the Company’s holders of Common Stock, which the
Company shall use its commercially reasonable efforts to obtain as
soon as possible, but in no event later than the Company’s
next annual meeting, which shall be held no later than October 31,
2008, Purchaser shall not exercise the Warrant or the Additional
Warrant to the extent that, when taking into consideration any
restrictions placed upon issuances by the NASDAQ Marketplace Rules,
including rules governing aggregation of transactions, results in
an aggregate issuance of that number of shares of Common Stock
that, when combined with any penalty shares issued pursuant to the
Registration rights Agreement of even date herewith, is greater
than Nineteen and Nine-Tenth’s percent (19.9%) of the
Company’s total number of outstanding shares of Common Stock
as of the date of exercise.
ARTICLE IV
CONDITIONS
4.1.
Conditions Precedent to the Obligation of the Company to Close
and to Sell the Securities. The obligation
hereunder of the Company to close and issue and sell the Securities
to the Purchaser at the Closing is subject to the satisfaction or
waiver, at or before the Closing of the conditions set forth below.
These conditions are for the Company’s sole benefit and may
be waived by the Company at any time in its sole
discretion.
7
(a)
Accuracy of the Purchaser’s Representations and
Warranties . The representations and warranties of
the Purchaser shall be true and correct in all material respects
(except for those representations and warranties that are qualified
by materiality or Material Adverse Effect, which shall be true and
correct in all respects) as of the date when made and as of the
Closing Date as though made at that time, except for
representations and warranties that are expressly made as of a
particular date, which shall be true and correct in all material
respects (except for those representations and warranties that are
qualified by materiality or Material Adverse Effect, which shall be
true and correct in all respects) as of such date.
(b)
Performance by the Purchaser . The Purchaser
shall have performed, satisfied and complied in all material
respects with all covenants, agreements and conditions required by
this Agreement to be performed, satisfied or complied with by the
Purchaser at or prior to the Closing Date.
(c)
No Injunction . No statute, rule, regulation,
executive order, decree, ruling or injunction shall have been
enacted, entered, promulgated or endorsed by any court or
governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this
Agreement.
(d)
Delivery of Purchase Price . The Purchase Price
for the Securities shall have been delivered to the Company on the
Closing Date.
(e)
Delivery of Transaction Documents . The Transaction
Documents shall have been duly executed and delivered by the
Purchaser to the Company.
4.2.
Conditions Precedent to the Obligation of the Purchaser to Close
and to Purchase the Securities . The obligation
hereunder of the Purchaser to purchase the Securities and
consummate the transactions contemplated by this Agreement is
subject to the satisfaction or waiver, at or before the Closing, of
each of the conditions set forth below. These conditions are for
the Purchaser’s sole benefit and may be waived by the
Purchaser at any time in its sole discretion.
(a)
Accuracy of the Company’s Representations and
Warranties . Each of the representations and
warranties of the Company in this Agreement and the other
Transaction Documents shall be true and correct in all material
respects (except for those representations and warranties that are
qualified by materiality or Material Adverse Effect, which shall be
true and correct in all respects) as of the date when made and as
of the Closing Date as though made at that time, except for
representations and warranties that are expressly made as of a
particular date, which shall be true and correct in all material
respects (except for those representations and warranties that are
qualified by materiality or Material Adverse Effect, which shall be
true and correct in all respects) as of such date.
(b)
Performance by the Company . The Company shall
have performed, satisfied and complied in all material respects
with all covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the
Company at or prior to the Closing Date.
8
(c)
No Suspension, Etc . Trading in the Common Stock
shall not have been suspended by the Commission or the Nasdaq
Capital Market (except for any suspension of trading of limited
duration agreed to by the Company, which suspension shall be
terminated prior to the Closing), and, at any time prior to the
Closing Date, trading in securities generally as reported by
Bloomberg Financial Markets (“ Bloomberg ”)
shall not have been suspended or limited, or minimum prices shall
not have been established on securities whose trades are reported
by Bloomberg, or on the New York Stock Exchange, nor shall a
banking moratorium have been declared either by the United States
or New York State authorities, nor shall there have occurred any
material outbreak or escalation of hostilities or other national or
international calamity or crisis of such magnitude in its effect
on, or any material adverse change in any financial market which,
in each case, in the judgment of the Purchaser, makes it
impracticable or inadvisable to purchase the Securities.
(d)
No Injunction . No statute, rule, regulation,
executive order, decree, ruling or injunction shall have been
enacted, entered, promulgated or endorsed by any court or
governmental authority of competent jurisdiction which prohibits
the consummation of any of the transactions contemplated by this
Agreement.
(e)
No Proceedings or Litigation . No action, suit
or proceeding before any arbitrator or any governmental authority
shall have been commenced, and no investigation by any governmental
authority, to the Company’s knowledge, shall have been
threatened, against the Company or any Subsidiary, or any of the
officers, directors or affiliates of the Company or any Subsidiary
seeking to restrain, prevent or change the transactions
contemplated by this Agreement, or seeking damages in connection
with such transactions.
(f)
Opinion of Counsel . The Purchaser shall have
received an opinion of counsel to the Company, dated the date of
the Closing, substantially in the form of Exhibit E annexed
to the 2007 Purchase Agreement, with such exceptions and
limitations as shall be reasonably acceptable to counsel to the
Purchaser.
(g)
Debenture and Warrant . At or prior to the
Closing Date, the Company shall have delivered to the Purchaser the
Warrant (in such denominations as the Purchaser may
request).
(h)
Officer’s Certificate . On the Closing
Date, the Company shall have delivered to the Purchaser a
certificate signed by an executive officer on behalf of the
Company, dated as of the Closing Date, confirming the accuracy of
the Company’s representations, warranties and covenants as of
the Closing Date (except those representations and warranties made
as of a specific date) and confirming the compliance by the Company
with the conditions precedent set forth in paragraphs (b) to (e)
and (i) of this Section 4.2 as of the Closing Date (provided that,
with respect to the matters in paragraphs (d) and (e) of this
Section 4.2, such confirmation shall be based on the knowledge of
the executive officer after due inquiry).
9
ARTICLE V
CERTIFICATE
LEGEND
5.1.
Legend . Each certificate representing the
Securities shall be stamped or otherwise imprinted with a legend
substantially in the following form (in addition to any legend
required by applicable state securities or “blue sky”
laws):
|
|
THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “ SECURITIES
ACT ”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD,
TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE
SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR
ELECTRO ENERGY, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL THAT
REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND UNDER
THE PROVISIONS OF APPLICABLE STATE SECURITIES LAWS IS NOT
REQUIRED.
|
|